Extended Data Fig. 2: Tumour rechallenge. | Nature Biomedical Engineering

Extended Data Fig. 2: Tumour rechallenge.

From: Synthetic libraries of immune cells displaying a diverse repertoire of chimaeric antigen receptors as a potent cancer immunotherapy

Extended Data Fig. 2

The surviving mice xenografted with N3 or B16 tumours given CAR-T library immunotherapies were rechallenged with N3 (a), BN16 (b), or SW480 (c−d) tumours, respectively. Control mice with tumour burden after implantation are included for comparison. The data are presented as the means ± s.d. (a-d). P values are from a two-side nonparametric t-test (a-c).

Source data

Back to article page